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Summary 
(NZB  x  NZW) F1 (BWF1) mice develop spontaneous T cell autoimmunity to VH region de- 
terminants of syngeneic anti-DNA before the onset of clinical disease. In this study, we charac- 
terized the immunogenicity, MHC binding, and lymphokine secretion patterns induced by T 
cell determinants from the VH region of one such anti-DNA mAb (A6.1) and examined their 
role in the regulation of autoimmunity. Determinants were identified by proliferation of syn- 
geneic splenic T  cells from young, unprimed BWF1  mice in response to overlapping 12-mer 
peptides representing the entire Vu region sequence.  Immunization of young BWF1 mice with 
any of three determinants (A6H 34-45 [p34],  A6H 58-69 [p58], and A6H 84-95  [p84])  elicited 
proliferative responses upon in vitro recall. Upon immunization with the whole A6.1 molecule, 
however, proliferative responses could be recalled only to the p58 peptide, defining this as im- 
munodominant. The other two peptides (p34 and p84) elicited minimal or no proliferation and 
could be termed cryptic. Proliferative responses elicited by the cryptic determinants were restricted 
by a single class II (I-E  d for p34 and I-A u for p84), whereas the immunodominant p58 deter- 
minant was restricted by both bE d and I-E  u. The cryptic p34 and p84 bound strongly to I-E  a 
and I-A u, respectively, whereas the immunodominant p58 peptide bound poorly to I-E  a. A6H 
p84 elicited T cells that secreted lymphokines in a pattern consistent with a Thl-like phenotype, 
whereas p58 induced a Th2-1ike cytokine pattern. Immunization with p34 or p84, or adoptive 
transfer of a p84-reactive T cell line to young BWF1 mice significantly increased IgG anti-DNA 
levels, accelerated nephritis, and decreased survival.  In conclusion, in BWF1 mice, autoreactive 
T  cells recognizing both cryptic and dominant self-determinants on anti-DNA autoantibodies 
escape deletion or anergy induction. Furthermore, since these cells are spontaneously activated 
before the onset of clinical disease, they may be involved in the development of the autoimmune 
process. 
S 
LE is characterized by loss  of tolerance to self-antigens 
and persistent production  of autoantibodies  (autoAb) 1 
(1, 2).  Both B and T  cells contribute to the production of 
pathogenic autoAbs and development of autoimmune dis- 
ease (1-3). Th cells have been shown to upregulate produc- 
tion of anti-DNA Abs both in vitro and in vivo (4-7). How 
This paper was presented  in part at the Annual Meeting  of the Clinical 
Immunology  Society,  in Anaheim, CA, on April 1994. Portions of this 
work have appeared in abstract form (1994. j. Immunol. 152:3215a). 
1 Abbreviations used in this paper: autoAb, autoantibody;  BWF1, (NZB x 
NZW) F1; BUN, blood urea nitrogen; CWF1, (BALB/c x NZW) F1; 
HEL, hen egg lysozyme;  PPD, purified  protein  derivative;  SI, stimulation 
index. 
are these Th cells activated, and to which determinants are 
they responsive?  In this study, we have focused on the inter- 
action between Ig-derived peptides and T cells and their poten- 
tial  involvement in disease  pathogenesis in a murine SLE 
model, (NZB  x  NZW) F1 (BWF1) mice. 
Unprimed young BWF1  mice, but not MHC-matched 
nonautoimmune mice, develop spontaneous T cell autoim- 
munity to VH region peptides of syngeneic IgG anti-DNA 
mAbs (reference 8 and Singh, R. R., F. Ebling, E. Sercarz, 
and B. H. Hahn, manuscript submitted for publication). Ac- 
cording to our working model, in autoAb-mediated diseases, 
autoAb molecules may be processed and presented to autoreac- 
rive  T  cells,  which would  then  stimulate B  cells,  finally 
resulting in increased production of pathogenic autoAbs and 
acceleration of clinical  disease. 
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minants from an mAb directed against DNA, termed A6.1, 
derived from a BWF1 mouse. In particular, we have studied 
the immunogenicity, MHC class II restriction, lymphokine 
secretion patterns, and pathogenic potential of three different 
T  cell determinants  (A6H 34-45  [p34],  A6H 58-69 [p58], 
and A6H 84-95 [p84]). Whether dominant or cryptic, these 
determinants elicited T cell proliferation and cytokine release 
and  accelerated autoAb  production  and  clinical  disease  in 
BWF1  mice. 
Materials and Methods 
Animals.  Female BWF1 and other mice were either obtained 
from the Jackson Laboratories  (Bar Harbor, ME) or bred in the 
UCLA Rheumatology Vivarium. To determine immunogenicity 
and class II restriction, the following strains were used: BALB/c, 
B10.GD, NZW, NZB, and (BALB/c  x  NZW) F1 (CWF1) mice. 
The MHC class II molecules of these strains  are shown in Fig. 
2. Animals were maintained in accordance with guidelines  of the 
UCLA Animal Research  Committee. 
L  Cell Transfectants.  The L cell transfectants RT 2.3.3H-D6 
(I-Ad),  RT 7.7I-I714.3 (I-Ec~aA~a), and RT 10.3B-C1 (I-E  a) were 
kindly provided by Dr.  Ronald Germain (National Institutes of 
Health, Bethesda, MD) and were used as described (9). The L cell 
transfectant 6A2 (I-A  u) was kindly provided by Dr. Patricia Jones 
(Stanford  University, Stanford, CA). 
Peptides.  Peptides used in initial screening tests were synthe- 
sized on pins,  as previously described  (8).  For these studies,  110 
overlapping  12-met  peptides  were  made,  each  overlapping  its 
neighbor by 11 amino acids (e.g.,  1-12,  2-13, etc.), representing 
the entire amino acid sequence of the VHDJH region of mAb A6.1. 
Each peptide, at concentrations of 1-10/~M, was incubated with 
1-5  x  l0  s T cell-enriched splenic cells from 12-14-wk-old  female 
BWF1  mice  and  3-6  x  10  s irradiated  syngeneic  splenic  cells 
(APCs).  After a 48-h incubation at 37~  in 7% COs, cells were 
labeled with [3H]thymidine, and proliferation was measured 18 h 
later.  Several peptides  consistently stimulated  splenic  T  cells to 
proliferate (mean stimulation indices [SI] 5.2-8.1 with <18% SEM) 
and were thus defined as T  cell determinants (Singh, R.  R.,  F. 
Ebling, E. Sercarz, and B. H. Hahn, manuscript submitted for pub- 
lication). 
Larger quantities of six peptides, three T cell determinants (see 
Fig. 1), and three control peptides were synthesized in the UCLA 
Peptide Synthesis Facility using Fmoc chemistry. Three peptides, 
none of which elicited spontaneous proliferation of naive BWF1 
T  cells, were used  as  controls:  (a)  A6H  93-107  (p93)  (ARD- 
SPYYYGSSYGFA), also derived from A6.1 VH, binds to the class 
II molecule I-A u (see Table 1) and induces a T cell proliferative re- 
sponse upon immunization (data not shown). (b) A modified p58 
(p58M) (FYNQ_AFKG__AATL),  in which lysines at positions 5 and 
9 in the wild-type peptide were substituted with alanines, did not 
stimulate unprimed syngeneic T ceils and was used as a negative 
control (8). (c) One I-Ed-binding immunodominant determinant 
of hen  egg  lysozyme, HEL  106-116 (HEL p106)  (NAWVAW- 
RNRCK),  was used as a positive control. Upon immunization, 
it elicits vigorous T cell proliferative responses in BWF1 mice. The 
synthetic peptides were analyzed for purity by HHPI.C and by mass 
spectrometry. Each peptide chromatographed essentially as a sharp 
single peak. All purified peptides were found to have the expected 
molecular mass. 
Immunization.  Mice were immunized at the base of their tails 
and hind footpads with 100/xg of purified A6.1 or 50/~g of different 
Ig-derived peptides, or with 5-7/~g of HEL p106, emulsified  1:1 
in CFA (Difco Laboratories, Inc., Detroit, MI). These immunizing 
doses gave optimal proliferation. 
Proliferation Assays.  8-10 d after immunization, draining LNs 
and spleens were collected. Lymphocyte suspensions were prepared 
by dissociating  LN and spleen tissues separately; cells were washed 
twice in HBSS medium. The LN or spleen cells (5  ￿  10  s cells 
per well) were incubated separately  in serum-flee HL-1 medium 
(Ventrex Laboratories,  Portland, ME) with 2 mM glutamine for 
5 d in fiat-bottomed, 96-well microtiter wells without peptide, with 
different concentrations of relevant or irrelevant peptides,  or with 
purified protein derivative of the tubercle bacillus (PPD; 700 U/ml) 
(Evans Medical Ltd., Langhurst, UK). The culture wells were pulsed 
with 1/~Ci of [3H]thymidine for the last  18 h of the assay. Cells 
in each well were harvested onto printed Filtermat A paper (Wallac, 
Turku, Finland) with a semiautomatic cell harvester (Skatron In- 
struments, Sterling, VA), and beta emissions  were measured in a 
beta counter (Beckman Instruments, Inc., Fullerton, CA). Results 
are recorded as mean cpm in triplicate wells; deviations  from the 
mean were <10% for all experiments. Positive control responses 
were those to PPD. Negative controls were wells without antigen 
and wells containing an irrelevant  peptide. Results are shown as 
SI: the ratio of cpm obtained with cells cultured in vitro with the 
relevant peptides versus cpm of cells incubated with medium alone, 
or as the mean triplicate Acpm, i.e., actual values of cpm obtained 
with cells stimulated in vitro with the relevant peptide minus the 
background (cells incubated with medium alone). 
Class II-Peptide-binding Assay.  Class II-peptide-binding assays 
were performed using purified I-E  d, I-A  d, and I-A  u class II mole- 
cules (in vitro I-Eu-spedfic binding assays are not available), as pre- 
viously described  (10). In brief, purified mouse class II molecules 
(5-500 riM) were incubated with 5 nM lzSI-labeled peptides  for 
48 h in PBS containing 5% DMSO in the presence of a protease 
inhibitor mixture. Class II-peptide complexes were separated from 
flee peptide by gel filtration on Sephadex G-50 or TSK2000 columns 
(Tosohaaf, Montgomen3rville, PA), and the fraction of peptide bound 
was calculated  as described (10). In the inhibition assays, peptide 
inhibitors were typically tested at concentrations ranging  from 
1.2 ng/ml to 120/~g/ml. The data were then plotted, and the dose 
yielding 50% inhibition was measured.  Each peptide was tested 
in two to four completely independent experiments. 
Inhibition of  Peptide.induced T Cell Proliferation by mA bs to Different 
Murine MHC Class H Molecules and to CD4 + T Cells.  Various di- 
lutions of culture supernatants or purified mAbs to class II mole- 
cules were added to LN or spleen cell cultures or peptide-reactive 
T cell line cultures containing the relevant peptides. The following 
mAbs were used:  MK-D6 (anti-I-A  a) (11), 10.2.16 (anti-I-A  ~,s,~) 
(12, 13), 14-4-4S (anti-I-Eot  k,u~) (13, 14), 34.4.4S (anti-I-Ed),  and 
GK1.5  (anti-CD4).  (Since  I-A" and  I-E  L,  the  designations  for 
NZW class II genes, are identical to I-A  u and I-E" [15], we have 
used the latter throughout this report.) 
Establishment of Peptide-specific T Cell Lines and Hybridomas.  T 
cell lines reactive to A6H peptides were prepared from LN ceils 
of adult BWF1 and one other strain (NZB for p34, BALB/c for 
p58, and NZW for p84), immunized s.c. with 50/~g of individual 
peptide in PBS, in 1:1 emulsion with CFA. After 10 d, the draining 
LNs were collected,  and single-cell  suspensions  were cultured at 
a concentration of 5  x  10  s cells/ml in DMEM supplemented with 
0.05 mM 2-mercaptoethanol, 2 mM t-glutamine, 1 mM pyruvate, 
gentamicin, and 10% FCS (complete medium) and with either rlL-2 
or rlL-4. After 7-10 d, the cells were stimulated with the relevant 
peptide and syngeneic irradiated splenic cells. The peptide specificity 
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well with 1-5  x  10  s irradiated syngeneic splenic cells in the ab- 
sence or presence of different concentrations of peptides. Prolifera- 
tion of T cell lines was measured by [3H]thymidine incorporation 
for the last  18 h of a 3-d culture. Peptide-specific cell lines were 
maintained by periodic restimulation with the relevant peptide and 
rlLo2 or rlL-4 every 10-14  d. 
T cell hybridomas were produced by fusion of peptide-reactive 
T cell lines from BWF1 mice with the cr  B- variant of BW5147 
(11). Peptide-specific hybridomas were subcloned, and the most reac- 
tive ones were selected for study. 
Detection of Lymphokines in Culture Supernatants.  Mice were im- 
munized with various doses of peptides in CFA. 9 d later, LN and 
spleen cells were collected and separately  cultured with medium 
alone, with PPD, or with the relevant peptide. Culture superna- 
rants were collected after 24--30 h for Ib2 detection and after 48-60 h 
for detection of IFN-y, IL-4, IL-5, and I1,10. II.,2 levels were de- 
tected by a standard bioassay using an I1,2 indicator cell line,  a 
subclone of CTLD2, which does not respond to rlL-4 (16). The 
proliferative responses of this cell line were blocked by the anti-mu- 
fine 1I+-2  mAb, $4B6 (17). Ib2 standard curves were generated using 
rll~2 (PharMingen, San Diego, CA). II,4 levels were detected by 
a standard  bioassay using an IL-4-dependent cell line, CT.4S (18) 
(kindly provided by Dr. William Paul, National Institutes of Health, 
Bethesda, MD). Proliferative responses of CT.4S were blocked by 
the anti-IL-4 mAb 11B.11 (19) (kindly provided by Dr. Craig Rey- 
nolds,  Biological Response Modifiers  Program, National Cancer 
Institute,  Frederick, MD). IL-4 was also detected by a capture ELISA 
using mAb pairs purchased from PharMingen. Standard curves were 
generated using rlL-4, which was generously provided by Dr. Steven 
Gillis (Immunex Corp., Seattle, WA). IFN-% IL-5, and IL-10  levels 
were determined by a capture ELISA using purified mAb pairs and 
rlFN-% ribS,  and rlL-10 as standards  (PharMingen) (20). 
Testing Pathogenic  Potential of  A6H Peptides in BWF1 Mice.  Two 
strategies were used: immunization with peptides in adjuvants and 
adoptive transfer of peptide-reactive T cell lines. (a) Immunization 
of young BWF1 mice with p34 or p84:  12-wk-old  BWF1 mice 
were immunized s.c. every 2 wk, at first with 100 #g of individual 
peptide in 1:1 emulsion with CFA and subsequently with peptide 
in alum, until 20 wk of age. Control mice received PBS in CFA 
followed by PBS in alum. In another experiment, 11-wk-old BWF1 
mice were immunized s.c. once either with all three determinants 
(p34, p58, and p84 separately in CFA on three consecutive days) 
or with a combination of two control peptides (p93 and HEL p106) 
in CFA. Both control peptides bind MHC class II molecules and 
are immunogenic in BWF1 mice, p93 binds I-A  ~ as does p84, and 
HEL  p106  binds  I-E  d,  as  does  p34.  (b)  Adoptive  transfer  of 
peptide-specific  T cell lines: a p84-reactive T cell line, which was 
maintained by periodic restimulation with peptide, irradiated syn- 
geneic APCs, and I1,4,  was activated by peptide  +  I1-2  +  11-4 
+  APCs 3 d before transfer.  On the day of transfer,  these cells 
were purified  on  Ficoll-Hypaque (Pharmacia,  Piscataway,  NJ), 
washed twice, and dissolved in HBSS. 1-4  x  106 cells per mouse 
were injected i.p.  at times 0 and at 2 wk. Control mice received 
HBSS alone. 
Assessment of Clinical Disease  BWF1 mice described in the above- 
mentioned experiments were monitored for survival and protein- 
uria and were bled for blood urea nitrogen (BUN), plasma creati- 
nine,  and  IgG  anti-dsDNA  Ab.  Proteinuria was  estimated by 
examination of fresh urine using Albustix (Ames, Elkhart, IN) on 
a scale of 0 to 4+, where 0/trace  =  negative, 1+  =  30, 2+  = 
100, 3+  =  300, and 4+  =  >2,000 mg/dl. BUN was estimated 
using Azostix (Ames) (21). Plasma creatinine was estimated by a 
colorimetric method  using  kits  and  standards  purchased  from 
Stanbio Laboratories  (San Antonio, TX). In normal (10-40-wk- 
old BALB/c) mice, plasma creatinine levels ranged from 0.3 to 0.6 
mg/dl. In unmanipulated BWF1 females, creatinine levels in pooled 
plasma of groups of eight mice at 10, 20, 30, and 40 wk of age 
were 0.6, 0.6,  1.3,  and 4.0 mg/dl, respectively. 
Measurement of Serum IgG Anti-double-stranded (ds) DNA At~ 
Antibodies to dsDNA were measured in serum samples by a stan- 
dard ELISA assay using calf thymus DNA, as previously described 
(21). Mean triplicate OD 405 nm values were recorded at serial 
serum dilutions. Anti-DNA titers are expressed as units per milli- 
liter,  using  a reference positive standard  of pooled serum from 
8-mo-old BWF1 mice. A 1:100 dilution of this standard serum was 
arbitrarily assigned  a value of 100 U/ml. 
Statistical Analysis.  Survival analysis using the log rank (Mantel- 
Haenszel) test was done to compare the proportion of surviving 
mice and the proportion of mice with no severe proteinuria in con- 
trol and test groups. Student's t test and Mann-Whitney U  test 
were also done to compare disease parameters between control and 
peptide-manipulated groups. 
Results 
Identification of T Cell Determinants in the Vu Of Anti-DNA 
mat+ A6.1.  Using 12-mer overlapping peptides representing 
the entire amino acid sequence of the VHDJH of mAb A6.1 
(21), we found several clusters of overlapping peptides that 
consistently induced in vitro proliferative responses in splenic 
T  cells from young nonimmunized BWF1 mice. The most 
stimulatory  peptides  in  these  clusters  were p34  from  the 
CDR1/FR2  region, p58 from the CDR2/FR3  region, and 
p84 from the FR3/CDR3 region (Fig. 1). In three additional 
BWF1  anti-DNA  mAbs  (two  using  the  VH  J558  gene 
family and one using 7183) (21), several peptides, including 
those similar to A6H determinants, were able to induce spon- 
taneous proliferative responses (Singh, R.  R., F. Ebling, E. 
Sercarz, and B. H.  Hahn,  manuscript  submitted for publi- 
cation). 
T Celllmmunogenicity  of  A6HPeptides in Young BWF1 Mice 
and MHC-identical Strains.  We compared the immunogenicity 
of these determinants  in  BWF1  females,  in their  parental 
strains, and in other MHC-identical strains. More specifically, 
the  mouse  strains  bearing  different combinations  of H-2  d 
and  H-2  u class  II  molecules  (as in  BWF1  mice) were im- 
munized with the various peptides in CFA (Fig. 2), and 8-10 d 
later, LN cell proliferation assays were performed. A6H p34 
elicited proliferative responses  only in  I-Ea-bearing  strains 
(i.e., BWF1, BALB/c, and NZB) and not in B10.GD, NZW, 
or B10.PL,  whereas p84-induced  responses were restricted 
to  H-2  u  strains  (BWF1,  NZW,  and  B10.PL).  A6H  p58 
elicited proliferative responses in either I-E  d- or H-2"-bearing 
strains, but not in the strain lacking these class II molecules 
(B10.GD mice). In terms of the magnitude of the responses 
observed,  p34  or p84  induced  strong  LN  and  spleen cell 
proliferative responses, whereas the response to p58 was weaker 
(Fig.  2). 
To characterize further the responses against these deter- 
minants,  peptide-specific T  cell lines were generated from 
BWF1  mice immunized with  individual peptides.  Each T 
cell line reacted specifically to the immunizing peptide (Fig. 
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Figure  1.  Amino acid sequence of 
A6.1 VaDJ, (21). T cell  determinants, 
namely, p34, p58, and p84, are shown 
in boxes. Each of these 12-met pep- 
tides induces proliferation  in splenic 
T  cells from unimmunized  12-14- 
wk-old BWF1  mice (Singh,  R. R., 
F. Ebling,  E.  Sercarz,  and  B.  H. 
Hahn, manuscript submitted for pub- 
lication),  and they can be defined as 
T  cell determinants  able  to  prime 
spontaneously  for a proliferative re- 
sponse. 
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Figure  2.  The immunogenicity  of A6H peptides in various normal and 
autoimmune mouse strains, having one or more of the class II molecules 
of BWF1 mice. 6-wk-old animals were immunized with individual pep- 
tides in CFA, and standard LN cell proliferation  assays were performed 
8 d later. Results are expressed as the mean SI from four to five animals 
3). A p84-reactive T cell line was used in adoptive transfer 
experiments,  as will be described. 
Finally, peptide-specific fresh LN/spleen cell proliferation 
in each case was completely inhibited by mAb GK1.5 (anti- 
L3T4), indicating that proliferating cells in LNs and spleens 
were CD4 + T  cells  (data  not shown). 
Immunodominance and Crypticity of A6H Peptides.  Proli- 
ferative responses  of draining LN calls  were also measured 
from mice immunized with whole A6.1 and recalled in vitro 
with either A6.1 or individual  peptides.  A6.1 elicited modest 
proliferation  in BWF1  mice,  but  minimal  proliferation in 
CWF1, NZB, and NZW (Fig. 4) (and in BALB/c mice; data 
not shown). Interestingly,  responses to peptide p58 were con- 
sistently higher than those to A6.1 itself in each strain, which 
is suggestive of a suppressive phenomenon by a determinant 
on the whole self molecule. Among the three T  cell deter- 
minants, p58 elicited the strongest in vitro proliferation in 
A6.1-primed mice in all of the strains tested (BWF1, CWF1, 
NZB, and NZW).  Thus, p58 was defined as immunodomi- 
nant. In contrast, p34 and p84 each elicited minimal prolifer- 
ation in three of eight BWF1 mice and none in CWF1, NZB, 
and NZW mice. Therefore, these two peptides can be con- 
sidered cryptic or subdominant (22). Differences in prolifer- 
ative responses  to p58 were significantly higher than those 
obtained with  p34  or p84  in  all  strains  (p <0.05,  Mann- 
Whitney  U  test). 
Binding of A6H Peptides to Murine Class II Molecules.  To 
characterize further the responses  to these peptides, their ca- 
pacity to bind various class II molecules was also measured, 
using  purified  I-A  or  I-E  molecules,  IoA d,  I-A u,  and  I-E a 
(Table 1). It was found that p34 bound very strongly to purified 
in each group, and they represent findings from one of two similar experi- 
ments.  Background  and PPD-positive  control cpm  x  103 values in var- 
ious experiments  in different mouse strains ranged  from 1.3 to 2.8 and 
94 to 195, respectively.  Note that p34 is immunogenic in I-Ed-bearing 
strains  (open symbols)  only and  p84  is  immunogenic in  H-2"-bearing 
strains (closed symbols~continuous lines), whereas p58 elicits proliferation in 
both I-E  d- and H-2~-bearing strains. None of these three peptides elicited 
proliferative responses in I-Ad-bearing BIO.GD mice (-x-x-). A negative 
control peptide, p58M, did not elicit proliferative responses in any of these 
strains; a positive control peptide,  HEL p106, elicited strong responses 
in I-E  d- bearing  strains and a control A6H peptide,  p93, was immuno- 
genic in I-Au-bearing  strains (data not shown). 
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Figure  3.  A6H peptide-derived T 
cell lines show no cross-reactivity with 
unrelated  peptides.  Proliferative  re- 
sponses of T cell lines derived from 
BWF1 mice immunized with the in- 
dividual peptide (I-q p34; ￿9  p58; and 
￿9  p84) were tested for their specifi- 
city. A standard proliferation assay of 
these T  cell lines was performed  in 
the presence of relevant (--)  or ir- 
relevant (- - -) A6H peptides.  Back- 
ground cpm values ranged from 1,200 
to  4,200.  Results  are  expressed  as 
Acpm and represent  one of at least 
three  experiments. 
Table  1.  Binding of A6H Peptides to Mouse Class II Molecules 
Peptide  I-E  a  I-A  a  I-A" 
heM  #M  #M 
p34  0.044  >700  297 
p58  18  >700  193 
p84  >700  >700  0.087 
p93  >700  >700  0.29 
The amount of each peptide  required  to inhibit the binding by 50% of 
12SI-labeled h repressor  12-26 to I-E  d and 12SI-labeled  RO tV to I-A  d and 
I-A  u was measured  (10). For each assay, the 50% inhibitory concentra- 
tions of a control standard inhibitor was also measured. These values were 
0.15/zM for )x repressor  12-26 binding to I-E~, 0.11  /zM for binding 
of OVA 323-336  to I-A  d, and 8.0 nM for binding of RO IV to I-A  u. 
The values represent  the average of two to four completely independent 
experiments. Determinants  p34, p58, and p84 elicit proliferative responses 
in naive BWF1  T  cells; p93  does not. 
I-E  a molecules, marginally  to IoA  u,  and not  at  all to bA d. 
In contrast, p84 bound well to I-A  u, but to neither I-A a nor 
I-E  d.  Finally,  p58 bound relatively weakly to I-E  a,  margi- 
nally to I-A  u,  and not  at  all  to bA  d. 
Determination of Class II Restriction of  A6H Peptides.  BWF1 
mice could present peptides in each of four class II molecules 
and,  possibly, in their hybrids (15,  23).  To determine class 
II restriction further,  LN cell cultures from peptide-immunized 
BWF1 mice were stimulated in vitro with the relevant pep- 
tide and incubated with various dilutions of mAbs to class 
II molecules. As shown in Fig. 5 A, p34-induced prolifera- 
tion was inhibited by anti-bE d but not anti-I-A d. Prolifera- 
tion induced by p84 in BWF1 and in NZW mice was not 
inhibited  by anti-I-A d or  anti-bE n,a, suggesting  that  this 
peptide, in agreement with the direct binding data, is presented 
by I-A u. Finally,  proliferation elicited by p58 was inhibitable 
by mAb 14.4.4S  (anti-I-E u,a) in BWF1 (Fig.  5 A), BALB/c, 
and NZW (data not shown) mice, suggesting that both I-E  d 
and  I-E  u molecules can present  the p58 peptide. 
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Figure  4.  Peptide p58 is immuno- 
dominant, and p34 and p84 are cryptic 
in most animals tested.  6-8-wk old 
BWF1 mice (n  =  8) and four each 
ofCWF1 (H-2-matched) and parental 
(NZB and  NZW) strains were im- 
munized with purified A6.1 in CFA. 
Recall proliferative responses to the 
whole molecule and to the individual 
peptides  were assayed in LN  cells. 
Results are expressed as mean -+ SEM 
SI at equimolar concentrations of A6.1 
or peptides.  Background  and PPD- 
positive  control cpm  x  103  values 
ranged from 1.6 to 2.4 and 88 to 167, 
respectively. Results from one of four 
similar experiments  are shown here. A 
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Figure 5.  MHC class lI restriction 
of A6H peptide-induced responses. 
(A) T cell proliferation induced by 
A6H peptides is inhibited by mAbs 
to class II molecules. LN cells from 
BWF1 mice  immunized  with peptides 
were incubated  with an optimal dose 
of relevant peptide and increasing di- 
lutions of mAbs. Results are expressed 
as SI from one of three similar experi- 
ments. Background  cpm values  ranged 
from 900 to 1,800. A6H p34-induced 
proliferative  responses were inhibited 
by a mAb to I-E  a but not by anti- 
I-A  a, whereas p84-induced prolifera- 
tion was not inhibited by anti-l-E u,d 
or anti-l-A  a. (Anti-l-A"  mAb 10.2.16 
was stimulatory  in all our experiments 
on BWF1 and  NZW  mice.) A6H 
p58-induced  proliferation was  in- 
hibited by  anti-I-E"~  but  not  by 
anti-l-A  a. (B) Presentation of A6H 
peptides to peptide-specific  T cell hy- 
bridomas or lines by L cells  transfected 
with class II molecules. Proliferation 
of HT-2 (an IL-2/Ib4-sensitive cell 
line), cultured in the presence of su- 
pernatants obtained from T cell hy- 
bridomas or lines incubated  with rele- 
vant peptides and various L cell transfectants, is shown as SI. Results are from one experiment representative of three. L cells transfected with I-E  a 
but not those transfected with I-A  a, I-Ec~aA/3  a, or I-A  u presented p34 to its specific T cell line or p58 to its specific T cell hybridoma, whereas the 
I-A" transfectant presented p84 to a p84-reactive hybridoma. 
Similarly, proliferation of the peptide-reactive T cell lines 
was  inhibited by appropriate  anti-class  II mAbs  (data  not 
shown),  consistent  with  observations  in  primary LN  cell 
cultures. 
Previous MHC assignments were confirmed by using mu- 
fine class II-transfected L ceils as APCs incubated with peptide- 
specific hybridomas or T  cell lines (9). As shown in Fig.  5 
B, p34 and p58 were presented by I-Ed-transfected L  cells, 
whereas p84 was presented by I-Au-transfected (6A2),  but 
not by L  cells  transfected with  bA d,  I-EotdA3 d,  or I-E a. 
Thus, several lines of evidence suggest that p34 binds I-E  a 
and  p84  binds  I-A ~.  A6H  p58  appears  to  bind  both  I-E  a 
and I-E  u. 
Lymphokine Secretion Induced by A6H Determinants.  Primary 
LN cell culture supernatants  from BWF1 mice immunized 
with various peptides were analyzed for cytokine content; 
results are shown in Fig. 6. Determinant p34 elicited release 
of IL-2 and IFN-y,  as well as IL-4, indicative of a Th0 (or 
Thl  +  Th2) pattern ofcytokine production. Culture super- 
natants from p58-immunized BWF1 mice contained IL-4/IL-10 
and no IFN-',//IL-2 (Th2 pattern), whereas supernatants from 
p84-immunized mice contained IFN-qr and Ib2 but not IL-4, 
IL-10 (Fig. 6), or I1,-5 (data not shown), which is a Thl pat- 
tern. The control peptide, HEL p106, also elicited a Thl pat- 
tern (data not shown). In conclusion, each of the three pep- 
tides elicited a distinct cytokine profile, suggesting activation 
of distinct  Th cell subsets  (24). 
Immunization of Young BWF1 Mice with A6H Determinants 
Increases IgG Anti-DNA Production, Accelerates Clinical Dis- 
ease, and Reduces Survival.  Young BWF1 mice immunized 
with p34 or p84 had a significant increase in serum IgG anti- 
DNA Ab compared with PBS/CFA/alum-immunized mice 
(p <0.05)  (Fig.  7 A).  This increase in IgG autoAb was as- 
sociated with an increase in the proportion of mice developing 
severe nephritis  at  an earlier age (iv <0.01)  (Fig.  7 B)  and 
an increase in plasma creatinine levels (p <0.05) (Fig. 7 C). 
Mice were considered to have severe nephritis when they had 
>-300 mg/dl proteinuria on at least two consecutive exami- 
nations I wk apart and BUN levels >-30 mg/dl and/or plasma 
creatinine levels  >/1  mg/dl.  75%  of mice developed severe 
nephritis 8-10 wk earlier in the p34- or p84-immunized groups 
than in PBS/CFA-immunized group. The increased IgG au- 
toAb levels and impairment of renal function presumably led 
to decreased survival in peptide-immunized mice (p ~<0.01) 
(Fig.  7 D). 
In another experiment,  shown in Fig.  7 E, BWF1  mice 
immunized with a combination of all three determinants (p34 
+  p58  +  p84) in CFA developed severe nephritis much ear- 
lier than  mice immunized with  a mixture of two control 
peptides, p93  +  HEL p106, in CFA. A6H determinant- im- 
munized mice also had increased serum anti-DNA Ab (mean 
-  SEM,  107  +_.  16 vs 63  +_  15 U/ml, p  =  0.05-0.1,  Stu- 
dent's t test) and increased plasma creatinine (mean  _+ SEM, 
0.99  _  0.1 vs 0.73  _+ 0.06 mg/dl, p <0.05, Student's t test). 
A  p84-specific T  Celt Line Hastens Onset of Severe Disease 
in Young BWFI Mice.  Adoptive transfer of a p84-reactive 
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Figure 6.  Different  lymphokine se- 
cretion patterns  induced in LN cell 
culture by A6H peptides. Culture su- 
pematants from the LN cells of three 
to six immunized BWF1 mice were 
incubated in the absence (-) or pres- 
ence (+) of relevant peptides and as- 
sayed for IL-2, IFN-% Ib4, and IL- 
10.  None  of these  cytokines  were 
detected in the absence of antigen. 
The  PPD-positive control  levels of 
cytokines were  similar in all three 
groups of mice immunized with in- 
dividual peptides (data not shown). 
Results are shown as individual mouse 
values by a symbol.  Note that p84 
(,)  induced high levels of IL-2 and 
IFN-%  but  not  IL-4 and  Ibl0, 
whereas p58 (&) induced the reverse 
cytokine pattern.  A6H p34 (f-l) in- 
duced secretion of minimal levels of 
both types of cytokine (IL-2, IFN-3,, 
and ID4). 
line resulted in an increase in IgG anti-DNA Ab, an earlier 
onset of severe nephritis, increased plasma creatinine levels, 
and decreased survival compared with mice injected with HBSS 
(Fig.  8, A-D). 
Discussion 
There is ample evidence that B cells process endogenously 
synthesized Ig, and some of the resulting peptides are presented 
by class II molecules to T cells (25-27). Recent analyses of 
peptides eluted from class II molecules have provided further 
confirmation of very efficient natural B cell processing and 
presentation of endogenous Ig by class II molecules (28-30). 
It has been suggested that processing and presentation of self-Ig 
V region peptides leading to induction of Th or T regula- 
tory cells may be important in regulation of immune responses 
and repertoire (25, 31, 32) and may also play a role in the 
induction and maintenance of autoimmune processes. To ex- 
plore this possibility,  we searched for autoreactive  T  cells 
capable of recognizing peptides derived from autoAb to DNA 
in autoimmune BWF1 mice. Multiple T cell determinants 
were  identified:  three  major  determinants  derived  from 
four different anti-DNA  mAbs  share  very similar motifs 
(Singh, R. K., F. Ebling, E. Sercarz, and B. H. Hahn, manu- 
script submitted for publication). Recently, peptides corre- 
sponding to CDR/FR regions similar to our A6H determi- 
nants (p58 and p84) have been eluted from class II molecules 
(28, 30).  IgGVH 59-74 (XNADFKTPATLTVDKP), span- 
ning CDR2/FR3, eluted from I-A  b (28) is somewhat similar 
to p58 (A6.1 58-69 in the CDR2/FR3).  Similarly, peptide 
(XSAVYYXAKRRQ),  corresponding to the FK3/CDR3 
region of Ig VH, eluted from HLA DR2/DR5 (30) is quite 
similar to p84 (A6.1 VR 84-95 in the FR3/CDR3) (Fig. 1). 
Analysis of the hierarchy in determinant dominance in A6.1 
revealed that p58, which showed the weakest binding to the 
class II  molecule bE  a,  proved  to  be  the  dominant deter- 
minant. Apparently,  immunodominance in this instance de- 
pends on preferential processing of the determinant, perhaps 
owing to its easier availability, high affinity TCR binding, 
or promiscuity for class II molecules (I-E  ~ and I-Eu), rather 
than affinity for MHC molecules (20, 33, 34). It is interesting 
that some cryptic determinants bind strongly to class II mole- 
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Figure  7.  Upregulation of systemic autoimmunity by autoAb-derived T cell determinants.  (A-D)  Groups of eight 12-wk-old BWF1 mice were im- 
munized once  with p34 ([]),  p84 ('),  or PBS ([]),  in a  1:1 emulsion with CFA  and subsequently  in alum emulsion every 2 wk until 20 wk of 
age.  Results  are shown as mean  _+  SEM (for serum IgG anti-dsDNA Ab and for plasma creatinine levels) and as the proportion  of mice surviving 
and the proportion  of mice with no severe nephritis,  (.4)  Mean  +  SEM IgG anti-DNA levels were increased in BWF1  mice immunized with p34 
or p84 compared with levels in PBS/CFA-immunized mice (*p <0.05, Student's t test). (B) The log rank (Mantel-Haenszel)  test was done to compare 
the proportion  of mice not developing  severe nephritis,  which was higher  in the control  group  than in mice immunized with p34 ~  =  0.001)  or 
p84 (p  =  0.009).  (C) Mean  +  SEM plasma creatinine levels were elevated in peptide-immunized mice (*p <0.05,  **p  =  0.05-0.1,  Mann-Whitney 
U test). (/9) The increase in anti-DNA Abs and renal abnormalities was associated with decreased survival in peptide-immunized mice. Survival analysis 
was done using a log rank (Mantel-Haenszel)  test (p  =  0.008,  p34; p  =  0.01,  p84).  Results  of another  experiment  are shown in (E).  Eight mice 
immunized with one injection  each of p34,  p58,  and p84 in separate emulfions in CFA had a statistically  significant  increase in the proportion  of 
mice developing  severe nephritis  compared  with mice immunized with two control  peptides  (p  =  0.004,  log rank  test), 
cules, again stressing the fact that crypticity  is not synony- 
mous with weak MHC binding. Weaker proliferative responses 
to p58 after immunization with the peptide itself, compared 
with cryptic p34 or p84, may be caused by its poor MHC 
binding capacity. Normally,  dominant self determinants in- 
duce tolerance (22). However, because of its low MHC-binding 
affinity, some p58-reactive T cells might escape negative selec- 
tion and thus be responsible for the presence of autoreactive 
T cells specific for this determinant. Self-tolerance may have 
eliminated other immunodominant T cell reactivities against 
better MHC-binding peptides. 
Correlation between peptide and MHC affinity and cytokine 
pattern has recently been shown in various systems (35, 36). 
High affinity interactions  tend to result in the activation of 
Thl cells, as exemplified by p84 and HEL p106. By contrast, 
the Th2-1ike cytokine pattern induced by p58 may be due 
to its low MHC affinity. Autoantigen-specific  Th2 responses 
may be of particular interest in the pathogenesis  of autoAb- 
mediated systemic autoimmunity. Frequent injections of an- 
tibodies to II.-10, a Th2 cytokine, have been shown to delay 
substantially the onset of autoimmunity in BWF1 mice (37). 
In contrast,  diversion  of autoantigen-specific  responses  to- 
ward Th2 or inhibition of Thl responses has been shown 
to be protective in several models of T cell-mediated, organ- 
specific autoimmune diseases (24, 38, 39). However, the strict 
requirement of Th2-1ike cells in the pathogenesis of SLE may 
be debated, since autoreactive Th clones of all subsets (Th0, 
Thl, and Th2) have been shown to induce IgG anti-DNA 
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anti-DNA Abs of the IgG2a isotype (usually Thl dependent 
[40]) are capable of inducing lupus nephritis in normal mice 
(21). The Th2 cytokine-inducing  p58 as well as p34 and p84, 
which elicit Th0 and Thl cytokine patterns, respectively, in- 
creases in vitro IgG anti-DNA formation in ELISPOT assays 
(Ebling, F. M., R. R. Singh, and B. Hahn, manuscript in 
preparation). Since there may be cyclic evolution of Thl and 
Th2 predominance, it would be interesting to follow their 
relative  contributions at different stages  of SLE. 
It is interesting to analyze our findings in terms of the 
pathogenesis of autoimmunity in BWF1 mice. Spontaneous 
T  cell autoimmunity to multiple VH region determinants 
from autoAb (anti-DNA mAbs), but not to those from a 
foreign (anti-HEL) mAb, develops before the onset of clin- 
ical disease in BWF1 mice. These determinants are recog- 
nized by autoimmune BWF1 T cells but not by T cells from 
MHC-matched, nonautoimmune CWF1 or normal BALB/c 
or NZW mice (Singh, R. R., F. Ebling, E. Sercarz, and B. H. 
Hahn, manuscript submitted for publication). Also, significant 
T cell proliferative  responses to the whole autoAb molecule 
(A6.1) are seen in autoimmune but not in normal mice (Fig. 
4). This might be caused by the presence ofT cells that recog- 
nize regulatory/suppressive determinants, which do not permit 
reactivity to the whole self protein in normal mice. Alterna- 
tively, autoreactive T ceils may escape tolerance only in auto- 
immune backgrounds, or the Ig may be processed differently 
in autoimmune and normal mice. 
Immunizations with dominant as well as cryptic deter- 
minants or adoptive transfer of a cryptic determinant-specific 
T cell line results in acceleration of clinical nephritis and de- 
creased survival in BWF1 mice (reference 8 and Figs. 7 and 
8). Thus, at the age when all of the peptide-treated BWF1 
mice had succumbed, >60% of the PBS-treated animals were 
still alive. These determinants, when incubated with unprimed 
T  and B cdls from young BWF1 mice, increase IgG anti- 
DNA production in vitro (Ebling, F. M., K. R. Singh, and 
B. Hahn, manuscript in preparation).  On the other hand, 
tolerance  induction by i.v. administration of these peptides 
drays the onset of nephritis and prolongs survival in BWF1 
mice (Singh, R. R., F. Ebling, E. Sercarz, and B. H. Hahn, 
manuscript  submitted for publication).  These predictable 
effects of  determinants potentially involved in regulation sup- 
port the notion that a Th-involved circuitry and spontaneous 
autoimmunity to these Ig-derived determinants constitute an 
immunoregulatory  pathway in the pathogenesis of  lupus, using 
some of the following mechanisms. (a) Regulatory/perpetu- 
ating role:  these determinants may play a role in the main- 
tenance of the autoimmune process, which has been induced 
earlier by some initiating antigen. A perpetual supply of these 
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Figure 8.  Adoptive  transfer of a p84-reactive T 
cell line to young  BWFI mice  leads to a significant 
increase in lgG anti-DNA (.4), an earlier onset of 
severe nephritis (B), increased  levels of plasma cre- 
atinine (C), and a decrease in survival (D). 11-wk- 
old BWF1 mice received  two i.p. injections  of 1-4 
x  10  e activated p84-reactive T cells (n =  16, ,) 
or of HBSS (n = 8,  O) at a 2-wk interval. In A 
and C, serum Ig-G anti-dsDNA and plasma creati- 
nine levels, respectively,  of individual  mice  at 6 mo 
of age and means of each group (horizontal lines) are 
shown (*p < 0.01, Student's t test). The proportion 
of surviving mice (/9) and the proportion of mice 
with no severe  nephritis (B) in the two groups was 
compared using the log rank (Mantd-Haenszd)  test 
(p  = 0.055 and 0.008, respectively). 
2025  Singh et al. determinants  from  autoAb  may induce  the  activation of 
peptide-specific  Th  cells,  which  in  turn  can  help  anti- 
DNA-producing B cells make more autoAb. (b) Induction 
or perpetuation by molecular mimicry: an Ig peptide that 
mimics a determinant on a self-Ag can induce autoimmuni- 
zation. Recent work has shown that strikingly different anti- 
genic determinants can cross-react with individual T cell clones 
(41). For example, administration of an MRL-lpr/lpr-derived 
Id-bearing Ig light chain, which has amino acid sequence 
homology with an antigenic region of the 70-kD U1 RNP 
polypeptide antigen, elicits  autoAbs against the 70-kD U1 
RNP autoantigen and DNA in BALB/c mice (42).  (c) In- 
duction/primary autoantigen role: because spontaneous auto- 
immunity to these peptides precedes the onset of clinical dis- 
ease, it raises the possibility that they may have a role in disease 
induction. Natural autoAbs and CD5 cells could provide one 
possible early source of these peptides. Peptides derived from 
natural autoAbs may activate Th cells capable of providing 
help for IgG anti-DNA Abs in genetically susceptible indi- 
viduals with appropriate T cell repertoires. It has been shown 
that immunization with a polypeptide from the VH region 
of a human anti-Sm Ab induces autoAbs in BALB/c mice (43). 
In conclusion, this study emphasizes that in autoimmune 
lupus mice, there are T cells capable of reacting to autoAb- 
derived peptides that have escaped the tolerance process. These 
T  cells may be linked to an immunoregulatory pathway, in 
which determinants from Ig VH enhance autoAb production 
and clinical disease. Downregulation of this pathway may be 
of significant therapeutic benefit in autoAb-mediated systemic 
diseases. 
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